Artialis has recently entered insolvency proceedings, and a curator has been appointed to oversee the process. This decision follows a period of sustained pressure on the life‑science and innovation ecosystem, driven by the current economic and geopolitical context, which has significantly affected funding, investment dynamics and project timelines across the sector.
Over the past years, Artialis has built strong scientific expertise and delivered high‑quality work for its partners, thanks to a highly committed and skilled team. The company’s employees have consistently demonstrated professionalism, scientific rigour and dedication, and their experience and capabilities remain a strong asset for the industry.
Artialis is fully cooperating with the curator to ensure an orderly and responsible handling of the situation. Employees, customers and partners have been informed directly, and further communication will follow as appropriate.